Skip to content

Arcus Biosciences RCUS Business Segments — Other segment items

Similar metrics at other companies

RingCentral logo
RNGReportable Segment — Other segment items
$482.6M+2.9%
Biohaven logo
BHVNReportable Segment — Other segment items
$14.46M-14.7%
WillScot Holdings Corporation logo
WSCReportable Segment — Other segment items
$71.71M-7.2%
BGC Group, Inc. logo
BGCReportable Segment — Other segment items
$251.24M+29.6%
UiPath logo
PATHReportable Segment — Other segment items
$57.32M-43.0%
MSC Industrial Direct Co. logo
MSMReportable Segment — Other segment items
$79.32M+13.3%

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's business segments — other segment items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's business segments — other segment items?
Arcus Biosciences (RCUS) reported business segments — other segment items of $20M in Q1 2026.
How has Arcus Biosciences's business segments — other segment items changed year-over-year?
Arcus Biosciences's business segments — other segment items decreased by 9.1% year-over-year, from $22M to $20M.
What is the long-term trend for Arcus Biosciences's business segments — other segment items?
Over 3 years (2022 to 2025), Arcus Biosciences's business segments — other segment items has grown at a 0.7% compound annual growth rate (CAGR), from $89M to $91M.
What does business segments — other segment items mean?
Captures miscellaneous operating expenses or income items that are not classified under primary development or personnel categories. This metric is used to track overhead and ancillary costs necessary to support the segment's broader business functions.